Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Dalton Transactions (Cambridge, England : 2003)|August 14, 2012
Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugsHristo P Varbanov, Seied M Valiahdi, Christian R Kowol, et al.Journal of Inorganic Biochemistry|September 15, 2015
Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategyDoris Höfer, Hristo P Varbanov, Anton Legin, et al.Dalton Transactions (Cambridge, England : 2003)|March 22, 2018
The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS studySarah Theiner, Márkó Grabarics, Luis Galvez, et al.Archiv Der Pharmazie|September 27, 2025
Loading of Dicarboxylatoplatinum(II)-NHC Complexes in Bacterial Ghosts as an Advanced Development in Cancer TherapyAmelie Scherfler, Klaus Wurst, Stefan Schwaiger, et al.Journal of Medicinal Chemistry|March 13, 2024
Development of Cytotoxic GW7604-Zeise's Salt Conjugates as Multitarget Compounds with Selectivity for Estrogen Receptor- Positive Tumor CellsPatricia Grabher, Paul Kapitza, Nikolas Hörmann, et al.Dalton Transactions (Cambridge, England : 2003)|May 25, 2021
Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamineSophia Harringer, Michaela Hejl, Éva A Enyedy, et al.Metallomics : Integrated Biometal Science|April 10, 2015
Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agentsSarah Theiner, Christoph Kornauth, Hristo P Varbanov, et al.Journal of Inorganic Biochemistry|March 18, 2025
Online OCHEM multi-task model for solubility and lipophilicity prediction of platinum complexesNesma Mousa, Hristo P Varbanov, Vidya Kaipanchery, et al.Journal of Medicinal Chemistry|July 18, 2014
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugsHristo P Varbanov, Simone Göschl, Petra Heffeter, et al.Pageof 2